How to Vet a Research Peptide Supplier: 10 Checks Before You Order

A research peptide supplier should be able to prove what is in every vial it sells. That proof starts with a certificate of analysis (COA) for each lot from a named independent laboratory, reporting high-performance liquid chromatography (HPLC) purity and mass spectrometry (MS) identity, and extends to the vial label, the spec sheet, the seller's research-use posture and its written business terms.

The ten checks below are a practical answer to how to choose a peptide supplier, and they apply to any seller. Each one explains why the check matters and names the red flag that should stop an order, and a summary table follows the checks.

Why does verifying a research peptide supplier matter?

Peptide products sold outside regulated supply chains have repeatedly failed basic identity and content tests. Anti-doping and medicines-control laboratories have documented these failures in peer-reviewed analyses of products bought online or seized by authorities.

These analyses describe illicit, falsified or black-market material, not every seller, and most were designed for doping or medicines control rather than research supply. They still show the failure modes that supplier documentation exists to rule out: the wrong molecule, the wrong amount of the right molecule, and impurities or contaminants that no label mentions.

Documentation checks: COAs, laboratories and raw data

1. A lot-matched COA for every lot

A certificate of analysis describes one production lot and nothing else. Pharmaceutical guidance makes this a basic requirement: the Q7A guidance for active pharmaceutical ingredients from the U.S. Food and Drug Administration (FDA) says authentic certificates of analysis should be issued for each batch on request and should give the batch number and date of release (FDA, 2001). For research peptides, the equivalent is a lot-matched COA, whose lot number matches the lot number on the vial character for character. How to Read a Peptide COA walks through every field on the report.

Red flag: one generic COA shown for every lot, a COA with no lot number, or identical test dates and purity figures across different lots.

2. A named, accredited third-party laboratory

Third-party tested peptides are only as credible as the laboratory behind the report. The COA should name the lab and give enough detail to contact it and confirm the report. The same FDA guidance expects certificates reissued by agents or brokers to show the name, address and telephone number of the laboratory that performed the analysis.

Accreditation adds an outside check. ISO/IEC 17025:2017, the testing-laboratory standard from the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC), sets requirements for the competence, impartiality and consistent operation of laboratories, and accreditation bodies use it to assess testing labs (ISO, 2017).

Red flag: an unnamed "independent lab", a lab logo with no address, or an accreditation claim that cannot be found in the accreditation body's directory.

3. HPLC purity and mass spectrometry identity, both

HPLC and MS answer different questions. HPLC separates a sample and reports the main peak's share of the material detected by ultraviolet (UV) absorbance, which shows how clean the sample is. MS measures molecular mass, which shows whether the main component is the intended molecule. A sample can pass one test and fail the other.

The black-market studies show why identity testing matters. Esposito et al. (2012) used HPLC coupled to high-resolution MS to show that a product sold as TB-500 contained a seven-residue fragment instead of the 43-residue peptide.

Red flag: a purity percentage with no identity test, or an "identity confirmed" line with no observed mass and no theoretical mass beside it.

4. Chromatograms and spectra, not just numbers

A purity figure is a calculation made from a chromatogram, so the chromatogram is the evidence. With the trace, a reader can see whether impurity peaks were integrated, how close they sit to the main peak, and whether the axes and run time are plausible. Even a good separation has blind spots: an impurity that co-elutes with the main peak is counted as product, one reason MS is run alongside HPLC, as How to Read a Peptide COA explains.

Red flag: a bare "99% pure" badge, a cropped chromatogram with no axes, or the same chromatogram image attached to several lots.

Product checks: the vial and the spec sheet

5. A lot number printed on every vial

The lot number is the only link between a physical vial and its COA. Without it, a published report cannot be tied to the material in a freezer, and a laboratory cannot trace an unexpected finding back to a production lot. PeppedCo prints the lot number on every vial, and anyone can look up a lot at /lab-testing/#verify.

Red flag: vials with no lot number, a lot number printed only on outer packaging, or a lot number that matches no published COA.

6. A full spec sheet that matches the molecule

A spec sheet should list the Chemical Abstracts Service (CAS) registry number, the full sequence, the molecular formula and the molecular weight, and all four should describe one molecule. Product names alone are unreliable, and TB-500 shows why.

Research catalogs commonly use TB-500 for synthetic thymosin β4: 43 residues, N-terminally acetylated, C212H350N56O78S, 4,963.4 g/mol, CAS 77591-33-4 (see the TB-500 spec sheet). FDA's compounding safety page, by contrast, lists "Thymosin beta-4, fragment (LKKTETQ), also known as TB-500" (FDA, 2026). Esposito et al. found that one product sold as TB-500 contained no full-length thymosin β4 at all, only the acetylated fragment Ac-LKKTETQ, with a mass of about 888 Da against about 4,963 Da for the full peptide. A sequence and a molecular weight settle which molecule is on offer.

Red flag: a product page with a name but no sequence, a molecular weight that does not fit the stated sequence, or a CAS number that belongs to a different compound.

Conduct check: a strict research-use posture

7. No dosing advice and no health claims

A supplier of materials for in-vitro research should discuss specifications, testing and laboratory handling, and nothing about use in people or animals. Dosing charts, preparation calculators, claims about effects in the body and customer testimonials all signal marketing to consumers, whatever the label says.

Regulators read the whole website, not only the disclaimer. In warning letters sent on August 24, 2026 to five online peptide vendors, FDA's Center for Drug Evaluation and Research (CDER) found that, despite research-use-only statements on the labeling, website evidence such as disease claims and dosing guidance showed the products were intended as drugs for human use (Kundi et al., 2026). A good supplier's content sticks to identity, testing and handling, with no statements about biological effects; What Is BPC-157? Sequence, Salt Forms and Regulatory Status is an example.

Red flag: dosing information in any form, before-and-after claims, testimonials, or a research-use disclaimer that the rest of the site contradicts.

Business checks: policies, support, payment and price

8. Clear shipping, reship and refund policies

Written policies show how a supplier handles the problems that eventually happen. A complete set covers:

• Carriers, delivery estimates and how vials are packed
• What happens when a package is lost or arrives damaged
• How many days a buyer has to report a problem
• Whether wrong or damaged items are reshipped or refunded

PeppedCo's terms are on its Shipping and Returns and reships pages, and handling after delivery is covered in How to Store Lyophilized Peptides.

Red flag: no written policy, "all sales final" with no exception for damaged or incorrect items, or terms that exist only in chat messages.

9. Identifiable support and documented payment terms

A buyer should be able to identify the business, reach a support address that answers within a stated time, and read how payment works before paying: accepted methods, when payment is taken and how refunds are returned. The payment method matters too. The Federal Trade Commission (FTC) warns that anyone who says the only way to pay is by bank transfer, wire transfer, cryptocurrency, payment app or gift card is probably a scammer, and notes that credit cards offer more protection, including the option to dispute charges (FTC, 2026).

Red flag: no business name, contact only through a messaging app, or payment accepted only through channels with no dispute process.

10. Prices that fit real synthesis and testing costs

Every legitimate vial carries the cost of solid-phase synthesis, HPLC purification, lyophilization, sealed glass vials and independent HPLC and MS testing of each lot. Longer sequences need more synthesis steps, so a 43-residue peptide costs more to make than a tripeptide. A price far below comparable listings leaves little room for those steps, and the analyses above show what can go missing: Janvier et al. (2018) found wide variation in peptide amount per unit among falsified peptide drugs from suspected illegal online pharmacies.

Red flag: prices far below comparable listings, permanent steep discounts, or one flat price for peptides of very different lengths.

The 10 checks for a research peptide supplier at a glance

Sourcing research peptides for laboratory research

Every PeppedCo lot is third-party tested before release: HPLC for purity and mass spectrometry for identity, with a purity release threshold of 98.0% or higher by HPLC. The COA for each released lot is published on the Lab Testing page, and PeppedCo provides no dosing, administration or reconstitution guidance (see the Research Use Policy).